As mentioned above, ATG4B could act as a pro-tumorigenic gene in cancers expressing it at a high level, including osteosarcoma, CML, HER2-positive breast and colorectal tumor cells. The gene discussed is ATG4B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.